MicroRNAs are independent predictors of outcome in diffuse large B-cell lymphoma patients treated with R-CHOP.
第一作者:
Alvaro J,Alencar
第一单位:
Department of Medicine, Division of Hematology-Oncology and Molecular and Cellular Pharmacology, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL 33136, USA.
作者:
医学主题词
青少年(Adolescent);成年人(Adult);老年人(Aged);老年人, 80以上(Aged, 80 and over);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);聚类分析(Cluster Analysis);环磷酰胺(Cyclophosphamide);DNA修饰甲基酶类(DNA Modification Methylases);DNA修复酶类(DNA Repair Enzymes);多柔比星(Doxorubicin);叉头转录因子类(Forkhead Transcription Factors);基因表达谱(Gene Expression Profiling);基因表达调控, 肿瘤(Gene Expression Regulation, Neoplastic);人类(Humans);Jurkat细胞(Jurkat Cells);淋巴瘤, 大B细胞, 弥漫性(Lymphoma, Large B-Cell, Diffuse);微RNAs(MicroRNAs);中年人(Middle Aged);肿瘤分期(Neoplasm Staging);泼尼松(Prednisone);预后(Prognosis);阻遏蛋白质类(Repressor Proteins);存活率分析(Survival Analysis);治疗结果(Treatment Outcome);肿瘤抑制蛋白质类(Tumor Suppressor Proteins);长春新碱(Vincristine);青年人(Young Adult)
DOI
10.1158/1078-0432.CCR-11-0224
PMID
21525173
发布时间
2025-05-29
- 浏览64
Clinical cancer research
4125-35页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



